Centre Hospitalier Universitaire (CHU) de Bordeaux - Hospitalier Saint-Andre
Bordeaux 33075
0 studies enrolling now · 3 studies all time
What they study most
Advanced or Metastatic NRAS-mutant Melanoma, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Hypertension
Studies at this site
- Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension — Completed
- A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) — Running, not enrolling
- Study of ALE.C04 in Patients With Head and Neck Cancer — Stopped early